TIM-3 on cancer cells has been shown to promote EMT and to regulate tumour biological behaviour through the MAPK, NF-κB, SMAD7/SMAD2/SNAIL1 and other signalling pathways [45]. The gene discussed is HAVCR2; the disease is neoplasm.